~~<i id='4D91B65C81'><strike id='4D91B65C81'><tt id='4D91B65C81'><pre id='4D91B65C81'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

fashion

author：focus 2025-10-04 06:24:58 - browse：55482

Roche HQ — SEBASTIEN BOZON/AFP via Getty Images

The multibillion-dollar hunt for what many drugmakers hope will be the next big immunotherapy target has had no shortage of twists and tea-leaf-reading. In the wee hours of Wednesday morning, it got another.

Roche confirmed it accidentally released interim data from a closely watched clinical trial testing whether blocking that target — a protein on T cells known as TIGIT — can enable non-small lung cancer patients to live longer than standard immunotherapy alone.

The announcement release came hours after Evercore analyst Umer Raffat emailed investors that he had found a presentation on a Roche media portal, presumably uploaded by accident.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Senators: Long

entertainment

leisure time

Wikipedia

knowledge

leisure time

hotspot

Sen.EdMarkeyofMassachusetts(above)andSen.JoeManchinofWestVirginiahadwordsofwarningforFDACommissioner

WSS

Drug for rare kidney disease narrowly misses mark in clinical trial

Readout Newsletter: Amylyx, Aurinia, and IQVIA

STAT Virtual Event: Putting AI to the Test

What Congress can do to address the rural doctor shortage

Why don't Americans have at

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Wikipedia

fashion

entertainment

Jerome Adams on the need for new antivirals for Covid

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Walensky prepares to leave CDC — and Congress — behind

Biotech stock slump in 2023: awaiting the turnaround

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout LOUD podcast: possible new ALS drug, artificial wombs

Sports medicine is finally prioritizing gender equality

Ebola vaccine can save some who are already sick, per new study

At least 13 dead in Texas as scorching temps continue

How AI helped researchers track recovery from depression

leisure time

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Resistance to opioid

Biotech lab space demand falls sharply

Congress must protect the remaining independent doctors

CDC advisers recommend seasonal use of Pfizer RSV shot

Resistance to opioid

Wikipedia

knowledge

leisure time

hotspot